Home > Products > Pharmaceutical intermediates
CasNo: 3516-95-8
MF: C15H14O2
Appearance: Slightly yellow crystals
From the aerial parts of Pepermia obtusi...
Chagas disease represents one of several...
We describe a novel reaction sequence fo...
The transfer hydrogenation of flavanones...
Biotransformation is an alternative with...
Acetylcholinesterase (AChE) inhibitors a...
Eight fungal strains (Penicillium raistr...
2-((Z)-3-hydroxy-3-phenylacryloyl)phenyl methylphenylcarbamate
2'-hydroxy-3-phenylpropiophenone
N-methyl-N-phenyl-3-phenylpropanamide
salicylic acid
Conditions | Yield |
---|---|
With water; sodium hydride; In tetrahydrofuran; for 24h; Reflux;
|
42% 42% |
Flavanone
(E)-2'-hydroxy-chalcone
2'-hydroxy-3-phenylpropiophenone
Conditions | Yield |
---|---|
With Rhodococcus sp. DSM 364; In acetone; at 28 ℃; for 168h; Microbiological reaction;
|
30% 13% |
Flavanone
2-hydroxychalcone
2-(5-phenyl-4,5-dihydroisoxazol-3-yl)phenol
(E)-2'-hydroxy-chalcone
1-(2-hydroxyphenyl)-3-phenyl-1-propanol
1-[2-(2-dimethylamino-ethoxy)-phenyl]-3-phenyl-propan-1-one
6-phenethyl-3,4-dihydro-2H-benzo[b][1,5]oxazocin-3-ol
2-benzyl-2-methoxy-benzofuran-3-one